Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Topical Powder

» Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Topical Powder contains the equivalent of not less than 90.0 percent and not more than 125.0 percent of the labeled amount of neomycin, and not less than 90.0 percent and not more than 120.0 percent of the labeled amounts of isoflupredone acetate (C23H29FO6) and tetracaine hydrochloride (C15H24 N2O2·HCl).

Packaging and storage— Preserve in well-closed containers.

Labeling— Label it to indicate that it is intended for veterinary use only.

USP Reference standards

—
USP Isoflupredone Acetate RS.
USP Neomycin Sulfate RS.
USP Tetracaine Hydrochloride RS.

Identification—

A: Thin-Layer Chromatographic Identification Test

201

—

Test solution— Add 20 mL of chloroform to 1 g of Topical Powder, shake for 5 to 10 minutes, and centrifuge. Evaporate a 10-mL portion of the clear solution to dryness, and dissolve the residue in 1 mL of a mixture of chloroform and alcohol (1:1).

Standard solution:

0.5 mg of USP Isoflupredone Acetate RS per mL, in a mixture of chloroform and alcohol (1:1).

Application volume:

30 µL.

Developing solvent system:

a mixture of methylene chloride and methanol (180:16), in a paper-lined chromatographic chamber.

Spray reagent:

a solution of sulfuric acid in methanol (70 in 100).

Procedure— Proceed as directed in the chapter, except to use a plate that has been activated by heating in an oven at 105

for 60 minutes. Allow the plate to cool before using. Locate the spots under short- and long-wavelength UV light. Spray the plate with Spray reagent, heat at 90

for 30 minutes, and locate the spots under short- and long-wavelength UV light (presence of isoflupredone acetate).

B: Thin-Layer Chromatographic Identification Test

201

—

Test solution— To 1 g of Topical Powder in a centrifuge tube add 5 mL of water, and shake until dissolved. Prepare a suspension of 10 g of cation-exchange resin in 10 mL of water, add 5 mL of a solution of sodium hydroxide (1 in 2), mix, and wash the resin with water until the pH of the wash is about 9. Add 0.3 g of this suspension to the solution of Topical Powder, and shake for 10 seconds. Centrifuge for 1 minute, and discard the supernatant. Wash the resin in the tube with 10 mL of water, centrifuge, and discard the supernatant. Add 2 mL of 1 M ammonium hydroxide, shake for 10 seconds, and filter. Use the filtrate.

Standard solution, Application volume, Developing solvent system, Spray reagent, and Procedure— Proceed as directed in Identification test A under Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Ointment (presence of neomycin).

Minimum fill

755

meets the requirements.

Loss on drying

731

— Dry about 2 g in vacuum at a pressure not exceeding 5 mm of mercury at 60

for 3 hours: it loses not more than 8.0% of its weight.

Assay for neomycin— Proceed as directed under Antibiotics—Microbial Assays

, the Test Dilution being prepared as follows. Use an accurately weighed quantity of Topical Powder diluted quantitatively with Buffer No. 3 to obtain a solution having a suitable concentration of neomycin. Dilute this stock solution quantitatively with Buffer No. 3 to obtain a Test Dilution having a concentration assumed to be equal to the median dose level of the Standard.

Assay for isoflupredone acetate—

Mobile phase, Diluent, Internal standard solution, Standard preparation, and Chromatographic system— Proceed as directed in the Assay under Isoflupredone Acetate.

Assay preparation— Transfer an accurately weighed portion of Topical Powder, equivalent to about 4 mg of isoflupredone acetate, to a suitable container. Add 8.0 mL of Internal standard solution, 32.0 mL of Diluent, and about 10 glass beads. Shake for about 15 minutes, centrifuge, and use the clear chloroform portion.

Procedure— Proceed as directed in the Assay under Isoflupredone Acetate. Calculate the quantity, in mg, of isoflupredone acetate (C23H29FO6) in the portion of Topical Powder taken by the formula:

WS(RU / RS)

in which the terms are as defined therein.

Assay for tetracaine hydrochloride—

Standard preparation— Prepare a solution having a known concentration of 5.5 µg of USP Tetracaine Hydrochloride RS per mL.

Assay preparation— Transfer an accurately weighed portion of Topical Powder, equivalent to about 5.5 mg of tetracaine hydrochloride, to a 100-mL volumetric flask, dilute with water to volume, and mix. Pass about 30 mL through a fine, sintered-glass filter. Transfer 10.0 mL of the clear filtrate to a second 100-mL volumetric flask, dilute with water to volume, and mix.

Procedure— Concomitantly determine the absorbances of the Standard preparation and the Assay preparation at the wavelength of maximum absorbance at about 310 nm, with a suitable spectrophotometer, using water to zero the instrument. Calculate the quantity, in mg, of tetracaine hydrochloride (C15H24N2O2·HCl) in the portion of Topical Powder taken by the formula:

1000C(AU / AS)

in which C is the concentration, in mg per mL, of USP Tetracaine Hydrochloride RS in the Standard preparation; and AU and AS are the absorbances of the Assay preparation and the Standard preparation, respectively.

Auxiliary Information— Please check for your question in the FAQs before contacting USP.

Topic/Question	Contact	Expert Committee
Monograph	Ian DeVeau, Ph.D. Director, Veterinary Drugs and Radiopharmaceuticals 1-301-816-8178	(VET05) Veterinary Drugs 05
Reference Standards	Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org

USP32–NF27 Page 3055

Pharmacopeial Forum: Volume No. 27(4) Page 2760

Chromatographic Column—

NEOMYCIN SULFATE, ISOFLUPREDONE ACETATE, AND TETRACAINE HYDROCHLORIDE TOPICAL POWDER

Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.